Related Experiment Videos
[True medicine? Economic analysis and perspectives for medical service]
R Walshe1, D Waldschmidt, V Diehl
1Klinik I für Innere Medizin, Universität zu Köln.
Der Unfallchirurg
|June 14, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
CONKO-006: A randomised double-blinded phase IIb-study of additive therapy with gemcitabine + sorafenib/placebo in patients with R1 resection of pancreatic cancer - Final results.
European journal of cancer (Oxford, England : 1990)·2020
[3D printing in fracture treatment : Current practice and best practice consensus].
Der Unfallchirurg·2022
[Subtrochanteric fractures].
Der Unfallchirurg·2022
[3D printing in the field of shoulder surgery].
Der Unfallchirurg·2022
[Update on 3D printing in the surgery of musculoskeletal tumors].
Der Unfallchirurg·2022
Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.
Journal of health services research & policy·2026
Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.
Health economics review·2026
Fever of unknown origin: cost of illness study.
Open medicine (Warsaw, Poland)·2026
The potential usefulness of health asset valuation to promote health among Korean employees.
Scientific reports·2026
Hospitalization costs and out-of-pocket expenses for stroke patients in mainland China.
BMC health services research·2026